70 results
SC 14D9/A
SNCE
Science 37 Holdings Inc
4 Mar 24
Tender offer solicitation (amended)
6:01am
include agreements regarding future terms of employment, the right to receive equity or equity-based awards of eMed or retention awards. As of the date … elected to proceed with the transaction without a fairness opinion from William Blair. Additional information pertaining to the retention of William
SC 14D9
SNCE
Science 37 Holdings Inc
12 Feb 24
Tender offer solicitation
9:03am
of eMed or retention awards. As of the date of this Schedule 14D-9, no compensation arrangements between such persons and eMed and/or its affiliates have … certain liabilities that may arise, out of William Blair’s engagement. Additional information pertaining to the retention of William Blair by Science 37
SC 14D9
EX-99
SNCE
Science 37 Holdings Inc
12 Feb 24
Tender offer solicitation
9:03am
and/or disaster recovery procedures or any bona fide document retention policy in effect as of the date hereof, in each case, in the ordinary course
SC TO-T
EX-99
SNCE
Science 37 Holdings Inc
12 Feb 24
Third party tender offer statement
8:16am
and/or disaster recovery procedures or any bona fide document retention policy in effect as of the date hereof, in each case, in the ordinary course of business
SC TO-T
EX-99
SNCE
Science 37 Holdings Inc
12 Feb 24
Third party tender offer statement
8:16am
current industry needs around patient recruitment, retention, representation, and engagement. To expand clinical trial access, Science 37 offers … employment, severance, change in control, retention, bonus (whether annual, transactional or otherwise), guarantee or similar agreement or arrangement
8-K
EX-2.1
w3ithv
29 Jan 24
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment
7:35am
SC TO-I
EX-99
omiej6c3bk001
3 Apr 23
Issuer tender offer statement
8:00am
SC TO-I
EX-99
omkv2b
3 Apr 23
Issuer tender offer statement
8:00am
SC TO-I
EX-99
blg 1ct6bp0d8ot1xx6
3 Apr 23
Issuer tender offer statement
8:00am
S-8
EX-99.1
lnu8tz7 oty8bvwilb
10 Nov 22
Registration of securities for employees
4:32pm
424B3
vhpql3pu81 z4
10 Nov 22
Prospectus supplement
4:23pm
8-K
EX-99.1
5ctqhu68qh
10 Nov 22
Science 37 Reports Third Quarter 2022 Financial Results
4:05pm
8-K
EX-99.1
3m2vn2ue80rxrt5z
5 Oct 22
Science 37 appoints Paul von Autenried to its Board of Directors
4:17pm
8-K
EX-99.1
6cv 6qloq3
12 Sep 22
Science 37 Names Industry Veteran Michael Shipton as Chief Commercial Officer
7:59am
424B3
zd2jncihrgk rrpd4jbs
11 Aug 22
Prospectus supplement
6:37am